Markets:

Overview

News

Currencies

International

Treasuries

Clearmind Medicine Inc. - Common Shares (NQ:CMND)

2.230 -0.060 (-2.62%)

Streaming Delayed Price Updated: 12:54 PM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clearmind Medicine Inc. - Common Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical Trial Evaluating CMND-100 in Patients with Alcohol Use Disorder

May 22, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

May 19, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket ↗

May 19, 2023

Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of...

Via Benzinga

Why Is IN8bio (INAB) Stock Up 9% Today? ↗

April 26, 2023

IN8bio (INAB) stock is rising higher on Wednesday as the biopharmaceutical company's shares continue their wild swings this week.

Via InvestorPlace

Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity

May 17, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More ↗

May 15, 2023

Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths...

Via Benzinga

Benzinga Pro's Top 5 Stocks To Watch For Friday, May 12, 2023: CMCSA, KR, ON, TSVT, CMND ↗

May 12, 2023

Comcast (CMCSA) - The parent company of NBCUniversal. One of Friday's most-discussed stories stemmed from a tweet by Elon Musk he had found a new exec to file the chief exec role at Twitter.

Via Benzinga

Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol Use Disorder

May 12, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

EXCLUSIVE: Clearmind Medicine Secures Approval To Launch Clinical Trial For Alcohol Addiction Treatment ↗

May 12, 2023

Clearmind Medicine Inc.

Via Benzinga

Clearmind Medicine Retains Crescendo Communications LLC. for Investor Relations and Announces Granting of Stock and Warrants

May 09, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More ↗

May 08, 2023

EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations

Via Benzinga

Clearmind Medicine Strengthens Scientific Advisory Board with Appointment of Prof. Joseph Tam

May 08, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Next-Gen Israeli Psychedelics Company Gears Up For Trial Targeting Alcohol Addiction ↗

May 03, 2023

Alcohol Use Disorder (AUD) is one of the top-targeted health issues by biopharma companies. In the case of Clearmind Medicine (NASDAQ: CMND), the Israel-based company is going at it through its...

Via Benzinga

Clearmind Medicine Announces Clinical Supply Agreement for its Upcoming Clinical Trial

May 02, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine Forms a Data and Safety Monitoring Board to Oversee its First-in-Human Clinical Trial

April 27, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Why Meta Platforms Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket ↗

April 27, 2023

Gainers

Via Benzinga

Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 27, 2023

Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its...

Via Benzinga

Why Is ZyVersa Therapeutics (ZVSA) Stock Down 46% Today? ↗

April 26, 2023

ZyVersa Therapeutics (ZVSA) stock is sliding lower on Wednesday following a couple of announcements from the biopharmaceutical company.

Via InvestorPlace

Why Chipotle Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 26, 2023

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 105% to $0.1730 after the company issued a letter to shareholders.

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket ↗

April 26, 2023

Gainers

Via Benzinga

Why Is Clearmind Medicine (CMND) Stock Up 45% Today? ↗

April 26, 2023

Clearmind Medicine (CMND) stock is taking off on Wednesday even without any recent news from the psychedelic medicine company.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 26, 2023

It's time for another dive into the biggest pre-market stock movers that investors need to know about on Wednesday morning!

Via InvestorPlace

Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More ↗

April 24, 2023

LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a...

Via Benzinga

SciSparc And Clearmind Collaboration Strengthens IP Portfolio With Patent Application For Treatment Of Depression ↗

April 21, 2023

SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that as part of its...

Via Benzinga

Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression

April 21, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression

April 21, 2023

From SciSparc Ltd

Via GlobeNewswire

Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off ↗

April 20, 2023

Monash University Engages LaNeo MDMA Australian Monash University’s psychedelics research lab has contracted MDXX-class molecules developer PharmAla Biotech to manufacture and supply its clinical-grade...

Via Benzinga

Clearmind Medicine Engages Experienced Contract Research Organization to Support its First-in-Human Clinical Trial

April 20, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Why Is Gamida Cell (GMDA) Stock Down 19% Today? ↗

April 19, 2023

Gamida Cell (GMDA) stock is falling on Wednesday after the cell therapy company revealed details of a public securities offering.

Via InvestorPlace

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.